Soergel David bought MDGL

March 4, 2026 · Form 4 insider transaction

Soergel David bought 5,467 shares of Madrigal Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction
Acquired (buy-side)
Shares
5,467
Price
$0.00
Total value
N/A
Role
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 4, 2026
Filing dateMarch 6, 2026
Shares owned after5,467
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

View the original Form 4 on SEC EDGAR